Drug firm Jubilant Life Sciences today said its board would consider raising up to Rs 1,000 crore through issuance of non-convertible debentures.
"The Board of Directors of the company shall at its meeting scheduled to be held on October 27, 2016 inter-alia consider the proposal to issue non-convertible debenture up to an amount of Rs 1,000 crore," Jubilant Life Sciences said in a filing to BSE.
The company however did not provide any details about what it proposes to do with the amount to be raised.
Jubilant stock closed at Rs 686.75, up 0.54 per cent, on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
